Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Drug-Related Side Effects and Adverse Reactions × camrelizumab × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Sarcoma 7 Osteosarcoma 3 Liposarcoma 1 Drug-Related Side Effects and Adverse Reactions 1 Chordoma 1

Interventions

apatinib 3 Ifosfamide 2 Filgrastim 2 Etoposide 2 selinexor 1 glucarpidase 1 camrelizumab 1 Vincristine 1 Radiotherapy 1 Procarbazine 1 Pharmaceutical Preparations 1 Methotrexate 1 Lomustine 1 Imatinib Mesylate 1 Genetic Therapy 1 Fibroblast Growth Factor 7 1 Drug Combinations 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04351308 2020-05-19

MAPAC

Peking University People's Hospital

Phase 2 Unknown

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡